Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Clinical Proteomics, 2015
A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers

Mahboob S., Ahn S., Cheruku H. et al.

Olink Target 96OncologyPatient StratificationPlasma

PLOS ONE, 2015
Low Elastin Content of Carotid Plaques Is Associated with Increased Risk of Ipsilateral Stroke

Asciutto G., Dias N., Edsfeldt A. et al.

Olink Target 96CVDNeurologyPatient StratificationBlood

Frontiers in Neurology, 2014
Cerebral Microdialysis for Protein Biomarker Monitoring in the Neurointensive Care Setting – A Technical Approach

Hillered L., Dahlin A., Clausen F. et al.

NeurologyTechnology Evaluation

PLoS ONE, 2014
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

Assarsson E., Lundberg M., Holmquist G. et al.

PROTEOMICS, 2014
Antibody‐based proteomics and biomarker research—Current status and limitations

Solier C., Langen H.

Technical StudiesTechnology Evaluation

Archives of Microbiology & Immunology, 2022
Circulating Cell-Free DNA and Systemic Inflammatory Response after Self-Expandable Metal Stent for Malignant Bowel Obstruction

Broholm M, Bojesen R, Gögenur M et al.

Olink Target 96OncologyPathophysiologyPlasma

Diagnostics, 2022
Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers

Razaghi A., Szakos A., Alouda M. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPleural Effusion Fluid

European Heart Journal Open, 2022
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients

Rossignol P., Duarte K., Bresso E. et al.

Olink Target 96CVDNephrologyPathophysiologyPatient StratificationPlasma

Obesity, 2022
The inflammatory proteome, obesity, and medical weight loss and regain in humans

Perry A., Tanriverdi K., Risitano A. et al.

Olink Target 96Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Clinical and Translational Science, 2022
ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study

Mi J., Wu X., Bai X. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Journal of Clinical Immunology, 2022
Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients

Ebihara T., Matsubara T., Togami Y. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma

Obesity, 2022
Proteomics, dietary intake, and changes in cardiometabolic health within a behavioral weight‐loss intervention: A pilot study

Hill E., Siebert J., Yazza D. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Cell Systems, 2022
Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection

Sauerwald N., Zhang Z., Ramos I. et al.

Olink Target 96Infectious DiseasesPathophysiologySerum

Journal for ImmunoTherapy of Cancer, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

Davis E., Martin-Liberal J., Kristeleit R. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Allergy, 2022
Development of sensitization to peanut and storage proteins and relation to markers of airway and systemic inflammation: A 24‐year follow‐up

Tedner S., Klevebro S., Bergström A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Journal of Proteome Research, 2022
Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia

Wang X., Yip K., He A. et al.

Olink Target 96ObstetricsPatient StratificationPlasma

Immunity, Inflammation and Disease, 2022
Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients

de Graaf D., Teufel L., de Nooijer A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Nature Genetics, 2022
Multiomics study of nonalcoholic fatty liver disease

Sveinbjornsson G., Ulfarsson M., Thorolfsdottir R. et al.

Olink Explore 3072/384HepatologyPathophysiologyPatient StratificationPlasma

Movement Disorders, 2022
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease

Bartl M., Dakna M., Schade S. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Nature Communications, 2022
Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma

Rabold K., Zoodsma M., Grondman I. et al.

Olink Target 96OncologyPathophysiologyPlasma

2846 publications